Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001308850 | SCV001498324 | uncertain significance | Fanconi anemia | 2022-11-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1011098). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (rs377167890, gnomAD 0.03%). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 1206 of the FANCM protein (p.Gln1206Glu). |
Ambry Genetics | RCV002543249 | SCV003546483 | uncertain significance | Inborn genetic diseases | 2022-07-14 | criteria provided, single submitter | clinical testing | The c.3616C>G (p.Q1206E) alteration is located in exon 14 (coding exon 14) of the FANCM gene. This alteration results from a C to G substitution at nucleotide position 3616, causing the glutamine (Q) at amino acid position 1206 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |